| Q92827608 | A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections |
| Q92697016 | Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST) |
| Q60044820 | Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial |
| Q38829346 | Appropriate surveillance methodology for assessing childhood antibiotic resistance: where do we stand? |
| Q90572968 | Early Bayesian Dose Adjustment of Vancomycin Continuous Infusion in Children: a Randomized Controlled Trial |
| Q39510473 | Empirical monotherapy with meropenem or combination therapy: the microbiological point of view |
| Q40789108 | Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014. |
| Q42650066 | Global shortage of neonatal and paediatric antibiotic trials: rapid review |
| Q38878914 | High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream Infections |
| Q96591145 | Human faeces-associated extended-spectrum β-lactamase-producing Escherichia coli discharge into sanitation systems in 2015 and 2030: a global and regional analysis |
| Q91675727 | Improvement of Guideline Adherence After the Implementation of an Antibiotic Stewardship Program in a Secondary Care Pediatric Hospital |
| Q59615054 | Management of children with multidrug-resistant sepsis in low-income and middle-income countries |
| Q90039031 | Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial |
| Q39941380 | Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study. |
| Q39155219 | Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study |
| Q92166228 | Pediatric Blood Cultures and Antibiotic Resistance: An Overview |
| Q31029810 | Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data |
| Q33575730 | Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolates |
| Q38689344 | The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria |
| Q38723961 | The role of solithromycin in the management of bacterial community-acquired pneumonia |
| Q28602817 | The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria |